Mar 28, 2023AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib...TOKYO and XIAMEN, March 27, 2023 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
Dec 21, 2022Premia and National Cancer Center Hospital East Announce the Initiation of the LC-SCRUM-AP Genomic..Establishing a large-scale lung cancer genomic screening platform in the Asia-Pacific region and promoting precision medicine for lung...
Nov 17, 2022AmoyDx® Pan Lung Cancer PCR PanelApprovedin Japan as a Companion DiagnosticforLUMAKRAS ®...TOKYO and XIAMEN, November 14th, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...
Aug 9, 2022MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek®...TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd....
Apr 20, 2022Filing Notice for a Manufacturing and Marketing Application for AmoyDx® Pan LungCancer PCR Panel...TOKYO and XIAMEN, April 20, 2022 -- Riken Genesis Co., Ltd., (“Rigen Genesis”), Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision...
Feb 24, 2022Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval...TOKYO and XIAMEN, February 23, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co.,...